The federal government may soon recommend flu shots without thimerosal, a preservative under scrutiny. Discover why this change matters and the implications for vaccine safety.
A recent NACCHO report reveals alarming staff shortages in local health departments, raising concerns about the public health safety net. As many as 19% report job losses, with funding cuts looming. Discover the implications for your community.
In a surprising move, federal vaccine advisers have voted to remove thimerosal from flu shots, aligning with anti-vaccine activists. This decision raises concerns about vaccine availability and public health.
In a surprising turn of events, Dr. Michael Ross has withdrawn from the vaccine advisory panel after a conflict of interest review revealed ties to private healthcare companies. This comes amidst ongoing scrutiny of the committee’s integrity.
The newly appointed vaccine advisory committee by Health Secretary Robert F. Kennedy Jr. is set to review childhood immunization practices, raising concerns among health experts about the implications for public health.
Sen. Bill Cassidy, once a champion of child vaccinations, faces backlash after supporting Robert F. Kennedy Jr. as HHS secretary, despite Kennedy's anti-vaccine stance and controversial committee changes.
In a bold move, Health Secretary Robert F. Kennedy Jr. announces eight new members to the CDC's vaccine advisory committee, some of whom have previously criticized vaccines, raising eyebrows and concerns about future recommendations.
In a controversial move, Health Secretary Robert F. Kennedy Jr. has replaced all members of the CDC's vaccine advisory panel with eight new appointees, raising concerns among public health advocates about potential anti-vaccine bias.
In a bold and controversial move, Health Secretary Robert F. Kennedy Jr. has dismissed the entire vaccine advisory panel, raising concerns about the future of immunization recommendations and public health trust.
HHS Secretary Robert F. Kennedy Jr. has dismissed the entire vaccine advisory panel, citing conflicts of interest. This unprecedented move raises concerns about vaccine safety and public health integrity.
